Stay updated on BCG and ALT-803 Combo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page.

Latest updates to the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe footer now identifies the website as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedAn NIH banner announces a website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.4%

- Check23 days agoChange DetectedThe site revision label changed from v3.7.1 to v3.7.2. The clinical trial record information remains unchanged.SummaryDifference0.1%

- Check30 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry v3.7.0 is now shown in the study history, while the previous revision v3.6.6 is no longer listed in the current history view.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry v3.6.6 was added to the history, and the previous revision v3.6.5 was removed, reflecting an update to the version history for the study record.SummaryDifference0.1%

Stay in the know with updates to BCG and ALT-803 Combo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page.